Kiromic BioPharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Jun 24 | Buy€2,415 | Brian Hungerford | Individual | 1,000 | €2.42 | |
12 Jun 24 | Buy€2,932 | Brian Hungerford | Individual | 1,000 | €2.93 | |
12 Jun 24 | Buy€18,005 | Pietro Bersani | Individual | 6,000 | €3.02 | |
12 Jun 24 | Buy€4,875 | Pamela Misajon | Individual | 1,610 | €3.04 | |
11 Jun 24 | Buy€3,105 | Michael Nagel | Individual | 1,000 | €3.10 | |
10 Jun 24 | Buy€4,639 | Pamela Misajon | Individual | 1,701 | €2.73 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 25,030 | 2.56% |
Individual Insiders | 34,177 | 3.49% |
Hedge Funds | 296,781 | 30.3% |
General Public | 623,255 | 63.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 87.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
179,653 | €508.4k | 996% | 2.1% | |||
60,762 | €171.9k | 0% | 0.56% | |||
56,366 | €159.5k | 180% | 0.65% | |||
21,453 | €60.7k | 0.83% | no data | |||
16,457 | €46.6k | 0% | no data | |||
6,296 | €17.8k | 0% | no data | |||
6,296 | €17.8k | 0% | no data | |||
3,566 | €10.1k | 0% | no data | |||
1,559 | €4.4k | 906% | no data | |||
1,365 | €3.9k | 0% | no data | |||
1,222 | €3.5k | -5.34% | no data | |||
809 | €2.3k | 0% | no data | |||
132 | €373.5 | 0% | no data | |||
40 | €113.1 | 0% | no data | |||
8 | €22.7 | 33.3% | no data | |||
4 | €11.4 | 100% | no data |